Literature DB >> 27229378

Regulation of monocyte induced cell migration by the RNA binding protein, FXR1.

O Le Tonqueze1, S Kollu1, S Lee1, M Al-Salah1, S S Truesdell1, S Vasudevan1.   

Abstract

FXR1 belongs to a family of RNA-binding proteins that play critical roles in post-transcriptional regulation of gene expression in immunity, development and cancer. FXR1 is associated with regulation of specific mRNAs in myocytes and macrophages. In quiescent cells (> 24 h of extended serum-starvation, ∼30-48 h or more), a spliced isoform of FXR1, FXR1a, promotes translation of the cytokine TNFα, independent of the effects of RNA levels. Here we examined the role of FXR1 in THP1 human monocytic leukemic cells that were grown in serum, as well as in early (24 h) serum-starvation conditions that demonstrates differences in gene expression mechanisms and is distinct from quiescent (> 24 h extended serum-starvation) cells. Global RNA profiling, conducted to investigate the role of FXR1 on mRNA levels, revealed that FXR1 affects levels of specific mRNAs in serum-grown and in early 24 h serum-starvation conditions. FXR1 decreases levels of several mRNAs, including as previously identified, CDKN1A (p21CIP1 or p21) mRNA in serum-grown cells. Interestingly, we find that FXR1 positively regulates mRNA levels of specific cytokines and chemokines in serum-grown and in early 24 h serum-starvation conditions. These include IL1β and CCL2 that control cell migration. Accordingly, depletion and overexpression of FXR1 decreased and increased levels of CCL2 mRNA. Consistent with the reduced levels of IL1β, CCL2 and other chemokines upon FXR1 depletion, our data reveal that depletion of FXR1 decreases the ability of these cells to induce cell migration of neighboring monocytic cells. These data reveal a new role of FXR1 in controlling induction of monocyte migration.

Entities:  

Keywords:  FXR1; cell migration; chemokines; gene expression; mRNA; monocyte

Mesh:

Substances:

Year:  2016        PMID: 27229378      PMCID: PMC4968908          DOI: 10.1080/15384101.2016.1189040

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  43 in total

Review 1.  Differentiation and heterogeneity in the mononuclear phagocyte system.

Authors:  D A Hume
Journal:  Mucosal Immunol       Date:  2008-08-27       Impact factor: 7.313

2.  Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha.

Authors:  S J Leibovich; P J Polverini; H M Shepard; D M Wiseman; V Shively; N Nuseir
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

Review 3.  Drugs interfering with apoptosis in breast cancer.

Authors:  Daniela Grimm; Markus Wehland; Jessica Pietsch; Manfred Infanger; Johann Bauer
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

4.  Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies.

Authors:  D Kontoyiannis; M Pasparakis; T T Pizarro; F Cominelli; G Kollias
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

5.  Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells.

Authors:  Giovanni Stefani; Claire E Fraser; Jennifer C Darnell; Robert B Darnell
Journal:  J Neurosci       Date:  2004-08-18       Impact factor: 6.167

6.  Novel isoforms of the fragile X related protein FXR1P are expressed during myogenesis.

Authors:  E W Khandjian; B Bardoni; F Corbin; A Sittler; S Giroux; D Heitz; S Tremblay; C Pinset; D Montarras; F Rousseau; J Mandel
Journal:  Hum Mol Genet       Date:  1998-12       Impact factor: 6.150

7.  Fragile X-related protein FXR1P regulates proinflammatory cytokine tumor necrosis factor expression at the post-transcriptional level.

Authors:  James Garnon; Claude Lachance; Sergio Di Marco; Zdenek Hel; Dominique Marion; Maria C Ruiz; Marianna M Newkirk; Edouard W Khandjian; Danuta Radzioch
Journal:  J Biol Chem       Date:  2004-11-17       Impact factor: 5.157

8.  Structure-function studies of FMRP RGG peptide recognition of an RNA duplex-quadruplex junction.

Authors:  Anh Tuân Phan; Vitaly Kuryavyi; Jennifer C Darnell; Alexander Serganov; Ananya Majumdar; Serge Ilin; Tanya Raslin; Anna Polonskaia; Cynthia Chen; David Clain; Robert B Darnell; Dinshaw J Patel
Journal:  Nat Struct Mol Biol       Date:  2011-06-05       Impact factor: 15.369

9.  ARED 3.0: the large and diverse AU-rich transcriptome.

Authors:  Tala Bakheet; Bryan R G Williams; Khalid S A Khabar
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

10.  MicroRNA-mediated mRNA translation activation in quiescent cells and oocytes involves recruitment of a nuclear microRNP.

Authors:  S S Truesdell; R D Mortensen; M Seo; J C Schroeder; J H Lee; O LeTonqueze; S Vasudevan
Journal:  Sci Rep       Date:  2012-11-13       Impact factor: 4.379

View more
  8 in total

1.  FXR1: Linking cellular quiescence, immune genes and cancer.

Authors:  Radhika Raheja; Roopali Gandhi
Journal:  Cell Cycle       Date:  2016-07-26       Impact factor: 4.534

2.  Analysis of MicroRNA-Mediated Translation Activation of In Vitro Transcribed Reporters in Quiescent Cells.

Authors:  Syed I A Bukhari; Samuel S Truesdell; Shobha Vasudevan
Journal:  Methods Mol Biol       Date:  2018

3.  Immunohistochemical Expression of FXR1 in Canine Normal Tissues and Melanomas.

Authors:  Laura Nordio; Andreia T Marques; Cristina Lecchi; Alberto M Luciano; Damiano Stefanello; Chiara Giudice
Journal:  J Histochem Cytochem       Date:  2018-04-02       Impact factor: 2.479

4.  Comprehensive Analysis of Differentially Expressed Profiles of mRNA N6-Methyladenosine in Colorectal Cancer.

Authors:  Na Li; Qin Guo; Qiao Zhang; Bai-Jun Chen; Xiao-An Li; Yan Zhou
Journal:  Front Cell Dev Biol       Date:  2022-01-07

5.  Early-Stage Lung Adenocarcinoma MDM2 Genomic Amplification Predicts Clinical Outcome and Response to Targeted Therapy.

Authors:  Abhilasha Sinha; Yong Zou; Ayushi S Patel; Seungyeul Yoo; Feng Jiang; Takashi Sato; Ranran Kong; Hideo Watanabe; Jun Zhu; Pierre P Massion; Alain C Borczuk; Charles A Powell
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.575

6.  FXR1 regulates transcription and is required for growth of human cancer cells with TP53/FXR2 homozygous deletion.

Authors:  Yichao Fan; Jiao Yue; Mengtao Xiao; Han Han-Zhang; Yao Vickie Wang; Chun Ma; Zhilin Deng; Yingxiang Li; Yanyan Yu; Xinghao Wang; Shen Niu; Youjia Hua; Zhiping Weng; Peter Atadja; En Li; Bin Xiang
Journal:  Elife       Date:  2017-08-02       Impact factor: 8.140

7.  RNA-binding protein FXR1 is presented in rat brain in amyloid form.

Authors:  Julia V Sopova; Elena I Koshel; Tatiana A Belashova; Sergey P Zadorsky; Alexandra V Sergeeva; Vera A Siniukova; Alexandr A Shenfeld; Maria E Velizhanina; Kirill V Volkov; Anton A Nizhnikov; Daniel V Kachkin; Elena R Gaginskaya; Alexey P Galkin
Journal:  Sci Rep       Date:  2019-12-12       Impact factor: 4.379

8.  Fragile X-Related Protein 1 (FXR1) Promotes Trophoblast Migration at Early Pregnancy via Downregulation of GDF-15 Expression.

Authors:  Wei Hong; Jin-Hong Chen; Hong-Jiao Ma; Xiao-Cui Li
Journal:  Reprod Sci       Date:  2021-07-21       Impact factor: 3.060

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.